LONDON, January 28, 2015 /PRNewswire/ --
Investor-Edge has initiated coverage on the following equities: Volcano Corporation (NASDAQ: VOLC), Stryker Corporation (NYSE: SYK), Edwards Lifesciences Corporation (NYSE: EW), ResMed Inc. (NYSE: RMD), and Varian Medical Systems Inc. (NYSE: VAR). Free research report on Pan American Silver can be accessed at http://get.Investor-Edge.com/pdf/?c=Pan%20American%20Silver&d=28-Jan-2015&s=PAAS. The US markets declined on Tuesday, January 27, 2015, as the Dow Jones Industrial Average finished at 17,387.21, down 1.65% and the NASDAQ Composite closed at 4,681.50, down 1.89%. The S&P 500 finished the session 1.34% lower at 2,029.55. During the trading session, nine out of ten sectors finished on a negative note. The S&P 500 Health Care Sector Index ended the day at 818.80, down 0.75%, whereas the index has gained 8.40% in the previous three months. Register for your complimentary reports at the links given below.
Volcano Corp.'s stock edged 0.06% lower, to close the day at the intra-day low of $17.97. The stock recorded a trading volume of 0.46 million shares, much below its three months average volume of 2.62 million shares. The company's shares oscillated between $17.97 and $17.99 during the session. Over the last three trading sessions and over the past one month, Volcano Corp.'s shares have advanced 0.11% and 0.45%, respectively. Further, the stock has rallied 81.52% in the past three months. The company's stock is trading above its 50-day and 200-day moving averages. Volcano Corp.'s 200-day moving average of $14.76 is above its 50-day moving average of $14.71. Additionally, the stock has a Relative Strength Index (RSI) of 82.09. Sign up and read the free notes on PAAS at:
http://get.Investor-Edge.com/pdf/?c=Pan%20American%20Silver&d=28-Jan-2015&s=PAAS
On Tuesday, shares in Stryker Corp. recorded a trading volume of 1.51 million shares, higher than its three months average volume of 1.24 million shares. The stock ended the day at $92.33, which was 0.24% below its previous day's closing of $92.55, and registered an intraday range of $91.34 and $92.98. Shares of the company traded at a PE ratio of 26.08. Stryker Corp.'s shares have fallen by 1.11% in the previous three trading sessions, while the stock has gained 9.42% in the last three months, and 20.98% in the past one year. The company's stock is trading above its 200-day moving average of $85.01, which is below the 50-day moving average of $92.92. Furthermore, shares of Stryker Corp. have an RSI of 47.40. The complimentary notes on EXK can be downloaded as in PDF format at:
http://get.Investor-Edge.com/pdf/?c=Endeavour%20Silver&d=28-Jan-2015&s=EXK
Edwards Lifesciences Corp.'s stock edged 0.58% lower to end Tuesday's session at $129.38. The stock recorded a trading volume of 0.55 million shares, below its three months average volume of 0.89 million shares. The company's shares fluctuated between $128.29 and $130.45 during the session. Shares of the company traded at a PE ratio of 44.63. Edwards Lifesciences Corp.'s shares have fallen by 0.40% over the last one month. However, the stock has surged 10.56% in the previous three months and 94.91% in the past one year. The company's stock is trading above its 50-day and 200-day moving averages. Edwards Lifesciences Corp.'s 50-day moving average of $129.29 is above its 200-day moving average of $102.31. Additionally, the stock has an RSI of 51.36. Register for free on Investor-Edge and access the latest research on SVM at:
http://get.Investor-Edge.com/pdf/?c=Silvercorp%20Metals&d=28-Jan-2015&s=SVM
On Tuesday, shares in ResMed Inc. fluctuated between $65.14 and $66.87 before ending the session 2.93% lower at $65.20. The stock reported a trading volume of 2.42 million shares, much higher than its three months average volume of 1.04 million shares. Shares of the company traded at a PE ratio of 26.46. ResMed Inc.'s stock has rallied 13.67% in the last one month, 26.48% in the previous three months, and 48.82% in the past one year. The company's stock is trading above its 50-day and 200-day moving averages of $56.04 and $51.83, respectively. Moreover, shares of ResMed Inc. have an RSI of 87.98. The complete research on TC is available for free at:
http://get.Investor-Edge.com/pdf/?c=Thompson%20Creek%20Metals&d=28-Jan-2015&s=TC
Shares in Varian Medical Systems Inc. finished Tuesday's session 0.24% lower at $87.07. A total of 0.99 million shares were traded, which was above its three months average volume of 0.67 million shares. The stock vacillated between $85.72 and $87.43 during the session. Over the last three months and over the past one year, Varian Medical Systems Inc.'s shares have gained 6.17% and 6.66%, respectively. However, in the previous three trading sessions, the stock has fallen by 1.34%. The company's shares are trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $87.44 is greater than its 200-day moving average of $83.88. Varian Medical Systems Inc.'s stock traded at a PE ratio of 22.03 and has an RSI of 50.74. Free in depth research on GPL is available at:
http://get.Investor-Edge.com/pdf/?c=Great%20Panther%20Silver&d=28-Jan-2015&s=GPL
About Investor-Edge.com
At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Investor-Edge
